Previous close | 0.0200 |
Open | 0.0200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 50.00 |
Expiry date | 2024-06-14 |
Day's range | 0.0200 - 0.0200 |
Contract range | N/A |
Volume | |
Open interest | 29 |
PRINCETON, N.J., May 29, 2024--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line...
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications....
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...